ONYX PHARMACEUTICALS INC — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ec713152-dd07-4879-90d4-19604186c009/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2012 | $-267.1M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-001966 |
| FY 2011 | $98.3M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-081975 |
| FY 2010 | $-68.3M | 2010-01-01 – 2010-12-31 | evidence 0000950123-11-017166 |
| FY 2009 | $20.2M | 2009-01-01 – 2009-12-31 | evidence 0000950123-11-017166 |
| FY 2008 | $-10.4M | 2008-01-01 – 2008-12-31 | evidence 0000950123-11-017166 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).